Correlation Between Kezar Life and MediciNova

Can any of the company-specific risk be diversified away by investing in both Kezar Life and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kezar Life Sciences and MediciNova, you can compare the effects of market volatilities on Kezar Life and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and MediciNova.

Diversification Opportunities for Kezar Life and MediciNova

-0.36

Correlation Coefficient

Kezar Life  MediciNova

Very good diversification

The 3 months correlation between Kezar and MediciNova is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Kezar Life i.e., Kezar Life and MediciNova go up and down completely randomly.

Pair Corralation between Kezar Life and MediciNova

Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 2.06 times less risky than MediciNova. The stock trades about -0.05 of its potential returns per unit of risk. The MediciNova is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  210.00  in MediciNova on September 30, 2024 and sell it today you would lose (3.00) from holding MediciNova or give up 1.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Kezar Life Sciences  vs.  MediciNova

Kezar Life Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kezar Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

MediciNova

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Kezar Life and MediciNova

The main advantage of trading using opposite Kezar Life and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.

The idea behind Kezar Life Sciences and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.